Aquinox Pharma Revenue, Profits - AQXP Quarterly Income Statement

Add to My Stocks
$15.29 $0.35 (2.34%) AQXP stock closing price Jun 15, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Aquinox Pharma stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2018 Q1 impacts the AQXP stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2018 Q1 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Aquinox Pharma profit and loss statement with those of the prior corresponding period. Also see Aquinox Pharma assets and Aquinox Pharma free cash flow for a complete valuation of AQXP stock.

View and download details of revenue and profits for Aquinox Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Aquinox Pharma Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
Aquinox Pharma Gross Profit
----------
Research & Development Expense10.5M11.57M8.45M10.47M5.77M8.14M6.13M9.23M4.88M3.94M
Selling General & Admin Expense4.3M4.98M3.61M3.52M2.74M3.34M2.14M1.83M1.95M1.67M
Income Before Depreciation Depletion Amortization-14.81M-16.53M-12.07M-13.99M-8.52M-11.47M-8.28M-11.06M-6.83M-5.61M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Aquinox Pharma Pretax Income
-14.62M-16.28M-11.83M-13.76M-8.31M-11.25M-8.14M-10.9M-6.71M-5.67M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-14.62M-16.27M-11.83M-13.77M-8.32M-11.24M-8.15M-10.9M-6.71M-5.66M
Extraordinary Items & Discontinued Operations----------
Aquinox Pharma Profit/ Loss (Net Income)
-14.62M-16.27M-11.83M-13.77M-8.32M-11.24M-8.15M-10.9M-6.71M-5.66M
Average Shares used to compute Diluted EPS23.48M23.45M23.47M23.44M23.42M23.63M17.69M17.21M17.21M20.97M
Average Shares used to compute Basic EPS23.48M23.45M23.47M23.44M23.42M23.63M17.69M17.21M17.21M20.97M
Income Before Nonrecurring Items-14.62M-16.27M-11.83M-13.77M-8.32M-11.24M-8.15M-10.9M-6.71M-5.66M
Income from Nonrecurring Items----------
Aquinox Pharma Earnings Per Share Basic Net
-0.62-0.69-0.50-0.59-0.36-0.48-0.46-0.63-0.39-0.27
Aquinox Pharma Earnings Per Share Diluted Net
-0.62-0.69-0.50-0.59-0.36-0.48-0.46-0.63-0.39-0.27
EPS Diluted Before Nonrecurring Items-0.62-0.69-0.50-0.59-0.36-0.48-0.46-0.63-0.39-0.27
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Aquinox Pharma stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2018 Q1. Our Aquinox Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-14.62M for Aquinox Pharma for 2018 Q1. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The AQXP financials along with Aquinox Pharma historical stock prices provide a lot of details about the firm.

Aquinox Pharma Income Statement - Key Financial Ratios